Health care funds have been far and away the big winners is this most nerve-racking year, returning more than 50% on
. But before you open up your wallet, take a look at how risky some of the funds have become.
Personal Finance Focus Saturday for
. He's screened the health care funds out there, and found that the best-performing outfits have loaded up on high-priced biotech stocks such as
. Given that the biotech sector has been feast or famine for the past decade, and given the chatter of a biotech bubble, it's worth checking out.
Also coming this weekend:
Tracy Byrnes' Investor Forum takes a close look at the aggressive initiatives on wash sale rules suggested in a recent Business Week column.
Mark Ingebretsen's Tools of the Trade examines whether artificial-intelligence software can succeed in predicting the markets.
Lee Barney reports on how mutual fund companies' in-house TV studios have boosted cash inflows and the celebrity status of managers, but not necessarily performance.
Also, check out
on mutual funds and much more. See you Saturday.